Algorae Pharmaceuticals Limited has released a press release.
Quarterly Activities/Appendix 5B Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Story so far
Earlier from Algorae Pharmaceuticals
- LCT commences AI-116 pre clinical studies
- Quarterly Activities/Appendix 4C Cash Flow Report
- Patent application over AI-116 for Dementia filed
- LCT Announces Shortfall Completion Notice
- Rights Issue Prospectus
Later from Algorae Pharmaceuticals
- CSIRO Grant for Artificial Intelligence Platform
- Addendum to September Quarterly Report
- 1AI commences AI-168 pre-clinical studies
- Algorae to list existing Option series on ASX
- Agreement with HL Pharma Addendum
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals